# Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

Study · id `cardio:ct-nct07589387` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07589387](<https://clinicaltrials.gov/study/NCT07589387>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07589387

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2800 participants.

## Technical summary

Registry record NCT07589387. Allocation not applicable; no masking; primary purpose health services research. Start 2026-02-14 (actual); primary completion 2029-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 2800 participants (planned count; ClinicalTrials.gov record NCT07589387, source copy `cardio:ctgov-nct07589387-2026-10-16`, retrieved 2026-10-26)
- Started: 2026-02-14 (actual) (ClinicalTrials.gov record NCT07589387, source copy `cardio:ctgov-nct07589387-2026-10-16`, retrieved 2026-10-26)
- Primary completion: 2029-04-30 (anticipated) (ClinicalTrials.gov record NCT07589387, source copy `cardio:ctgov-nct07589387-2026-10-16`, retrieved 2026-10-26)
- Completion: 2030-01-31 (anticipated) (ClinicalTrials.gov record NCT07589387, source copy `cardio:ctgov-nct07589387-2026-10-16`, retrieved 2026-10-26)
- Countries: Nigeria (ClinicalTrials.gov record NCT07589387, source copy `cardio:ctgov-nct07589387-2026-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07589387-2026-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3
- Acronym: HTN2
- Condition: Diabete Mellitus
- Intervention (Other): Implementation of program based on WHO HEARTS-D guidelines
- Intervention (Drug): Metformin
- Intervention (Drug): Glimepiride
- Intervention (Device): Point-of-care blood glucose monitor (glucometer) and compatible test strips
- Intervention (Behavioral): HEARTS-D training and quarterly supportive supervision for community health extension workers (CHEWs)
- Lead sponsor: Washington University School of Medicine
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: University of Abuja Teaching Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Washington University School of Medicine (`cardio:org-washington-university-school-of-medicine`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 72f9ab5609814d64b1cebe362eff3418b853c085f3b620c51fc0e1ec0ec444e5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
